Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1978 May;61(5):1355–1362. doi: 10.1172/JCI109053

The Role of Glucagon Deficiency in the Houssay Phenomenon of Dogs

Hajime Nakabayashi 1,2,3, Richard E Dobbs 1,2,3, Roger H Unger 1,2,3
PMCID: PMC372658  PMID: 659597

Abstract

Plasma glucose, immunoreactive glucagon (IRG), and insulin were measured in hypophysectomized dogs receiving cortisol and thyroid replacement therapy. 4 wk after hypophysectomy mean fasting plasma glucose levels had declined from 90±2 mg/100 ml to 64±2; fasting and arginine-stimulated insulin and IRG levels were, respectively, ∼50% lower and unchanged. 12 wk or more after hypophysectomy, despite lower plasma glucose levels, fasting and arginine-stimulated IRG levels were significantly below control dogs. Hypophysectomized and shamhypophysectomized dogs were subjected to total pancreatectomy. Postoperatively, in the sham-hypophysectomized, depancreatized dogs fasting glucose levels ranged from 300-500 mg/100 ml on 8-10 U/day of insulin; IRG levels averaged 215±29 pg/ml. The hypophysectomized, depancreatized dogs required 0-4 U/day and fasting glucose levels under 100 mg/100 ml were not uncommon, even without insulin; fasting IRG levels averaged 63±4 pg/ml (P < 0.001). During arginine infusion in sham-hypophysectomized, depancreatized dogs, IRG levels rose from 215±60 pg/ml to a peak of 404±112 pg/ml; in hypophysectomized, depancreatized dogs, the base line IRG averaged 44±8 and the peak 110±25 pg/ml (P < 0.05). IRG levels in the venous effluent of the gastric fundus, the major source of nonpancreatic glucagon, reached a peak of 4,898±959 pg/ml in the sham-hypophysectomized, depancreatized group during arginine infusion and only 219±128 pg/ml in the hypophysectomized, depancreatized group. In three hypophysectomized, depancreatized dogs, a replacement infusion with glucagon for 10 h promptly increased hyperglycemia by 80-180 mg/100 ml and worsened glycosuria, evidence of a hepatic response to glucagon replacement. It is concluded that hypophysectomy somehow decreased both the hypersecretion of gastric IRG and the severe hyperglycemia that otherwise follows pancreatectomy. The hypophysectomized, depancreatized animal, therefore, has combined insulin and glucagon deficiency, and the latter may contribute to reduced severity of its hyperglycemia.

Full text

PDF
1355

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Assan R., Slusher N. Structure-function and structure-immunoreactivity relationships of the glucagon molecule and related synthetic peptides. Diabetes. 1972 Aug;21(8):843–855. doi: 10.2337/diab.21.8.843. [DOI] [PubMed] [Google Scholar]
  2. BORNSTEIN J., REID E., YOUNG F. G. The hyperglycaemic action of blood from animals treated with growth hormone. Nature. 1951 Nov 24;168(4282):903–905. doi: 10.1038/168903a0. [DOI] [PubMed] [Google Scholar]
  3. Blazquez E., Muñoz-Barragan L., Patton G. S., Orci L., Dobbs R. E., Unger R. H. Gastric A-cell function in insulin-deprived depancreatized dogs. Endocrinology. 1976 Nov;99(5):1182–1188. doi: 10.1210/endo-99-5-1182. [DOI] [PubMed] [Google Scholar]
  4. FOA P. P., MAGID E. B., GLASSMAN M. D., WEINSTEIN H. R. Anterior pituitary growth hormone (STH) and pancreatic secretion of glucagon (HGF). Proc Soc Exp Biol Med. 1953 Aug-Sep;83(4):758–761. doi: 10.3181/00379727-83-20483. [DOI] [PubMed] [Google Scholar]
  5. Friedmann N., Exton J. H., Park C. R. Interaction of adrenal steroids and glucagon on gluconeogenesis in perfused rat liver. Biochem Biophys Res Commun. 1967 Oct 11;29(1):113–119. doi: 10.1016/0006-291x(67)90550-5. [DOI] [PubMed] [Google Scholar]
  6. GLASSER S. R., IZZO J. L. The influence of adrenalectomy on the metabolic actions of glucagon in the fasted rat. Endocrinology. 1962 Jan;70:54–61. doi: 10.1210/endo-70-1-54. [DOI] [PubMed] [Google Scholar]
  7. Herbert V., Lau K. S., Gottlieb C. W., Bleicher S. J. Coated charcoal immunoassay of insulin. J Clin Endocrinol Metab. 1965 Oct;25(10):1375–1384. doi: 10.1210/jcem-25-10-1375. [DOI] [PubMed] [Google Scholar]
  8. Marco J., Calle C., Román D., Díaz-Fierros M., Villanueva M. L., Valverde I. Hyperglucagonism induced by glucocorticoid treatment in man. N Engl J Med. 1973 Jan 18;288(3):128–131. doi: 10.1056/NEJM197301182880305. [DOI] [PubMed] [Google Scholar]
  9. Mashiter K., Harding P. E., Chou M., Mashiter G. D., Stout J., Diamond D., Field J. B. Persistent pancreatic glucagon but not insulin response to arginine in pancreatectomized dogs. Endocrinology. 1975 Mar;96(3):678–693. doi: 10.1210/endo-96-3-678. [DOI] [PubMed] [Google Scholar]
  10. Matsuyama T., Foà P. P. Plasma glucose, insulin, pancreatic, and enteroglucagon levels in normal and depancreatized dogs. Proc Soc Exp Biol Med. 1974 Oct;147(1):97–102. doi: 10.3181/00379727-147-38288. [DOI] [PubMed] [Google Scholar]
  11. Muñoz-Barragan L., Blazquez E., Patton G. S., Dobbs R. E., Unger R. H. Gastric A-cell function in normal dogs. Am J Physiol. 1976 Oct;231(4):1057–1061. doi: 10.1152/ajplegacy.1976.231.4.1057. [DOI] [PubMed] [Google Scholar]
  12. SCHMIDT F. H. ENZYMATISCHE METHODEN ZUR BESTIMMUNG VON BLUT- UND HARNZUCKER UNTER BERUECKSICHTIGUNG VON VERGLEICHSUNTERSUCHUNGEN MIT KLASSISCHEN METHODEN. Internist (Berl) 1963 Dec;4:554–559. [PubMed] [Google Scholar]
  13. Sasaki H., Rubalcava B., Baetens D., Blazquez E., Srikant C. B., Orci L., Unger R. H. Identification of glucagon in the gastrointestinal tract. J Clin Invest. 1975 Jul;56(1):135–145. doi: 10.1172/JCI108062. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Tai T. Y., Pek S. Direct stimulation by growth hormone of glucagon and insulin release from isolated rat pancreas. Endocrinology. 1976 Sep;99(3):669–677. doi: 10.1210/endo-99-3-669. [DOI] [PubMed] [Google Scholar]
  15. Van Lan V., Yamaguchi N., Garcia M. J., Ramey E. R., Penhos J. C. Effect of hypophysectomy and adrenalectomy on glucagon and insulin concentration. Endocrinology. 1974 Mar;94(3):671–675. doi: 10.1210/endo-94-3-671. [DOI] [PubMed] [Google Scholar]
  16. Vranic M., Engerman R., Doi K., Morita S., Yip C. C. Extrapancreatic glucagon in the dog. Metabolism. 1976 Nov;25(11 Suppl 1):1469–1473. doi: 10.1016/s0026-0495(76)80169-2. [DOI] [PubMed] [Google Scholar]
  17. Vranic M., Pek S., Kawamori R. Increased "glucagon immunoreactivity" in plasma of totally depancreatized dogs. Diabetes. 1974 Nov;23(11):905–912. doi: 10.2337/diab.23.11.905. [DOI] [PubMed] [Google Scholar]
  18. Wise J. K., Hendler R., Felig P. Influence of glucocorticoids on glucagon secretion and plasma amino acid concentrations in man. J Clin Invest. 1973 Nov;52(11):2774–2782. doi: 10.1172/JCI107473. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. YALOW R. S., BERSON S. A. Immunoassay of endogenous plasma insulin in man. J Clin Invest. 1960 Jul;39:1157–1175. doi: 10.1172/JCI104130. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES